Supernus Pharmaceuticals | SUPN - Action





Action Changement Date
Abbott USD 6.99B 501M 2026-03
ANI Pharmaceuticals USD 143.15M 319K 2026-06
Aurora Cannabis CAD 175.08M 55.48M 2026-03
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Canopy Growth CAD 110.51M 4.96M 2026-03
Cara Therapeutics USD 900K 0 2025-03
Corcept Therapeutics USD 13.18M 295K 2026-06
Eisai JPY 257.55B 21.09B 2026-03
Eli Lilly USD 16.79B 2.26B 2026-06
Novo Nordisk DKK 45.65B 21.26B 2025-06
Pacira USD 134.57M 15.8M 2026-06
Perrigo USD 1.06B 56.9M 2026-06
Pfizer USD 9.94B 722M 2026-06
Supernus Pharmaceuticals USD 107.03M 3.74M 2026-06
United Therapeutics USD 193.8M 15.5M 2026-06
Xeris Pharmaceuticals USD 80.93M 6.7M 2026-06